SpinalCyte Receives Australian Patent for Cartilage Repair

SpinalCyte was issued Australian Patent No. 2015202319, “Methods and Compositions for Repair of Cartilage Using an In Vivo Bioreactor.”

The patent addresses the production of chondrocytes or chondrocyte-like cells using fibroblasts in vivo with mechanical stress and low oxygen tension.

SpinalCyte’s patent portfolio includes 24 U.S....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us